Internet-delivered gut-directed hypnotherapy versus iCBT for stomach pain in children and teens
Official title: Internet-delivered Psychological Interventions for Pediatric Disorders of Gut-brain Interaction - a Randomised Controlled Study
Run by Karolinska Institutet · NCT07319078 · Data updated 2026-11-12
This trial will test whether online gut-directed hypnotherapy or internet-based cognitive behavioral therapy helps children and adolescents (8–17) with IBS, functional abdominal pain, or functional dyspepsia reduce stomach pain and improve daily life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 17 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | March 2030 |
| Study ends | March 2030 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT07319078 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are Swedish-speaking children and adolescents aged 8–17 with a Rome IV diagnosis of IBS, functional abdominal pain (FAP‑NOS), or functional dyspepsia who have completed basic medical testing and have a parent willing to engage in the online program.
✕Probably not a fit
Patients whose pain is better explained by an organic disease, who cannot use Swedish-language online materials, who cannot commit to regular homework or parent involvement, or who have recent changes in psychiatric medication are unlikely to benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares two digitally delivered psychological treatments — a gut-directed hypnotherapy program adapted from successful Dutch protocols and an internet-based cognitive behavioral therapy (iCBT) program — using a secure Swedish online platform. Participants and at least one parent complete educational modules, regular homework, and outcome questionnaires, with treatments delivered as home-based audio and web content. The research builds on a Swedish pilot and international evidence showing benefits of hypnotherapy for disorders of gut–brain interaction, and outcomes include symptom scales such as the PedsQL Gastro and measures of function and school attendance. Clinical eligibility requires confirmed DGBI diagnosis (Rome IV), basic medical work-up, language fluency in Swedish, and stable management of comorbid conditions prior to enrollment.
Why it matters
Potential benefit: If successful, this could give families a widely accessible, home-based treatment that reduces abdominal symptoms, improves quality of life, and shortens waits for care.
How similar studies have gone: Prior international trials, particularly from the Netherlands, have shown promising short- and long-term results for gut-directed hypnotherapy and have found home-based audio interventions to be as effective as face-to-face treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 8-17 years * Basic somatic work-up completed (CRP/ESR, TGA, complete blood count, fecal calprotectin) * Confirmed DGBI diagnosis: IBS, functional abdominal pain, or functional dyspepsia (according to Rome IV criteria) * Any constipation must be treated according to current clinical guidelines, with stable laxative dosing for at least one month prior to referral * In cases of celiac disease, the participant must have followed a gluten-free diet for at least six months and TGA values must have normalized * For participants with a neuropsychiatric diagnosis treated with medication, at least two months must have passed since the last dose adjustment * At least one parent and the child/adolescent must be fluent in Swedish and willing to participate in both the educational program and treatment (regardless of randomization outcome), complete homework assignments, and respond to questionnaires Exclusion Criteria: * Other organic disease that better explains the gastrointestinal symptoms * At referral assessment, psychiatric symptoms or psychosocial problems - such as severe bullying, high school absenteeism, or difficult family circumstances - are judged to be more prominent than the gastrointestinal problems and require more extensive, multiprofessional care than what the study can offer * Participants who have already completed gut-directed hypnotherapy or CBT
Where it's running
-
Sachs Children's Hospital
Stockholm, Sweden Recruiting
Study contacts
- Study coordinator: Tea Soini, MD PhD
- Email: tea.soini@ki.se
- Phone: +46 766457611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-FODMAP Diet vs Standard Dietary Advice for Functional Dyspepsia
This study tests whether a low-FODMAP diet helps adults with functional dyspepsia compared with standard dietary advice.
-
Relationship between body awareness and posture in IBS-C patients compared with healthy people
This study tests whether people with constipation-predominant IBS have different interoceptive awareness and posture compared with healthy controls.
-
Pain Reprocessing Therapy for Functional Dyspepsia
A small pilot test to see if a psychological therapy that uses exposure techniques can lessen digestive symptoms and help daily functioning in people with functional dyspepsia.
-
Identifying Signatures of Gut Interoception in Functional Dyspepsia and Anorexia Nervosa
This study tests how the gut-brain connection works in people with functional dyspepsia or anorexia nervosa using brain imaging.
-
Prevalence and possible role of non-H. pylori Helicobacter species in gastric conditions and cancers
Researchers will test stomach tissue from people with functional dyspeasia, various gastritis conditions, gastric cancer, and bariatric patients to see if non-H. pylori Helicobacter species are present.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.